Gilead Sciences Inc (GILD)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 5,665,000 | 4,592,000 | 6,225,000 | 123,000 | 5,386,000 |
| Total assets | US$ in thousands | 62,125,000 | 63,171,000 | 67,952,000 | 68,407,000 | 61,627,000 |
| ROA | 9.12% | 7.27% | 9.16% | 0.18% | 8.74% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $5,665,000K ÷ $62,125,000K
= 9.12%
Gilead Sciences, Inc.'s return on assets (ROA) has fluctuated over the past five years. In 2023, the ROA improved to 9.12% from 7.27% in 2022, indicating that the company generated more profit relative to its total assets. This improvement suggests better asset utilization and management efficiency in the most recent year.
In 2021, Gilead Sciences recorded an ROA of 9.16%, which was slightly higher than in 2023. This high ROA in 2021 reflected the company's ability to generate significant earnings from its assets.
However, there was a significant decline in ROA in 2020 to 0.18%, indicating a drastic reduction in profitability compared to the previous years. This sharp decrease might signal challenges in effectively utilizing assets to generate profits during that period.
Prior to 2020, Gilead Sciences consistently maintained relatively high ROA figures, with 8.74% in 2019. Overall, the recent trend in ROA for Gilead Sciences suggests a mix of fluctuations in asset efficiency and profitability over the analyzed period.
Peer comparison
Dec 31, 2023